Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Vitiligo patients often have nail problems, so checking their nails is important.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The microbiome may be linked to hair loss and could be a target for new treatments.

Sarcoidosis can cause various skin issues, making diagnosis difficult.

The CRH/CRH-R1 system might be involved in causing lichen planus.

The document lists various dermatology topics, treatments, and diagnostic methods.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

A brown shadow seen in dermoscopy is a marker for lichen nitidus.

A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.

The document concludes that understanding tissue degeneration is crucial for diagnosing skin lesions.

Skin problems after waxing led to a sarcoidosis diagnosis.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Skin reactions from cancer treatments might predict how well the treatments work.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.